Trials / Completed
CompletedNCT03747510
PAVmed CarpX Device Clinical Study
Prospective, Single-Center, Single Arm, Feasibility Study of the PAVmed CarpX Device for the Treatment of Carpal Tunnel Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- PAVmed Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To study the safety and feasibility of the CarpX device to divide and release the transverse carpal ligament in order to provide relief for Carpal Tunnel Syndrome (CTS).
Detailed description
This is a prospective, single center, single arm, study of the CarpX device for treatment of carpel tunnel syndrome. Patients will be followed for up to 30 days post procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CarpX Device | Transverse carpal ligament release with CarpX Device |
Timeline
- Start date
- 2019-01-05
- Primary completion
- 2019-12-30
- Completion
- 2019-12-30
- First posted
- 2018-11-20
- Last updated
- 2020-05-01
Locations
1 site across 1 country: New Zealand
Source: ClinicalTrials.gov record NCT03747510. Inclusion in this directory is not an endorsement.